Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-1...
Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
The mucosal immune response is recognized to be important in the early control of infection sustained by viruses with mucosal tissues as the primary site of entry and replication, such as SARS-CoV-2. Mucosal IgA has been consistently reported in the mouth and eye of SARS-CoV-2 infected subjects, where it correlated inversely with COVID-19 symptom s...
Alternative Titles
Full title
Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d3ebb77b2b29422f84222d125f83550a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d3ebb77b2b29422f84222d125f83550a
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v15122319
